06.13.24 -- Revolutionizing Modifier Gene Therapy Through A Gene-Agnostic Approach

The FDA has provided guidelines for the translation of studies conducted by non-US testing facilities, including an expectation that the translated report includes a statement of certification requirements.

In advanced therapy manufacturing, reducing human intervention and manual processes is critical to optimizing manufacturing paradigms, simplifying processes, and improving quality and efficacy.

This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

Learn about Organ-on-a-Chip technology and how it can be employed to assess the efficacy of CAR T-cell therapies against solid tumors.

As autologous cell therapies and other targeted gene therapies work to scale up to commercial levels, connections that can be changed out in seconds represent a distinct advantage for the industry.

When it comes to determining the appropriate analytics to inform early development, there are a number of variables to consider surrounding cost, operator expertise, and throughput.

Understand why proper training is vital in cleanroom cleaning and disinfection and how to develop and maintain a successful training initiative.

Gain a thorough understanding of active HEPA purging pass-throughs along with the numerous benefits associated with their use in cell and gene therapy facilities for material control.

Flexibility is crucial when an oncology patient lives far away from a clinical research site. Gain insight from industry experts about participant engagement and the realities of supporting oncology patients.

With each batch of cell and gene therapy product representing a wealth of lifesaving potential, this biopharma company needed the right packaging solution for its relatively new therapy applications.

Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.

Modeling and simulation can be a powerful tool for bioprocess design. Find out how you can utilize an open source implementation for in silico simulation of CHO.

Explore data resulting from an initial high-throughput screening experiment carried out to broadly evaluate anion exchange resins that exhibited high LVV recovery.